Back to VOLORIDGE INVESTMENT MANAGEMENT, LLC VOLORIDGE INVESTMENT MANAGEMENT, LLC

RARERARE
21 quarters

Position history for VOLORIDGE INVESTMENT MANAGEMENT, LLCVOLORIDGE INVESTMENT MANAGEMENT, LLC's holdings in ULTRAGENYX PHARMACEUTICAL IN

VOLORIDGE INVESTMENT MANAGEMENT, LLC holds 1.2M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $41.5M as of 2026-Q2. The position was decreased (-13.0% shares). RARE represents 0.2% of VOLORIDGE INVESTMENT MANAGEMENT, LLC's portfolio.

Current Value

$41.5M

Current Shares

1.2M

Total Value Change

+$40.5M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.2M
-13.0%
$41.5M0.2%$33.39
0
2026-Q1
Increased
1.4M
+121.8%
$29.9M0.1%$22.07
56
2025-Q4
Increased
643,356
+33.3%
$14.8M0.1%$22.78
36
2025-Q3
New
482,582
-
$14.5M0.0%$30.36
39
2024-Q4
Exited
0
-100.0%
$00.0%$42.27
0
2024-Q3
New
52,266
-
$2.9M0.0%$54.43
36
2023-Q3
Exited
0
-100.0%
$00.0%$35.65
0
2023-Q2
Decreased
19,027
-84.2%
$877,7160.0%$46.65
0
2023-Q1
Increased
120,474
+40.4%
$4.8M0.0%$38.64
36
2022-Q4
Increased
85,834
+385.1%
$4M0.0%$46.33
43
2022-Q3
New
17,695
-
$733,0000.0%$40.55
34
2022-Q2
Exited
0
-100.0%
$00.0%$60.24
0
2022-Q1
Decreased
26,295
-45.0%
$1.9M0.0%$71.36
0
2021-Q4
Increased
47,816
+306.8%
$4M0.0%$84.25
43
2021-Q3
Decreased
11,754
-58.7%
$1.1M0.0%$86.12
0
2021-Q2
Increased
28,456
+518.3%
$2.7M0.0%$96.29
42
2021-Q1
Decreased
4,602
-60.3%
$524,0000.0%$112.06
0
2020-Q4
Increased
11,585
+8.5%
$1.6M0.0%$144.37
28
2020-Q3
New
10,681
-
$878,0000.0%$85.10
34
2020-Q1
Exited
0
-100.0%
$00.0%$44.32
0
2019-Q4
New
21,635
-
$924,0000.0%$42.69
35

Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used